CRP and inflammatory bowel disease: A majority had elevated inflammatory markers including CRP and fecal calprotectin, which has previously been noted in patients with CVID and GI symptoms.6 We propose these symptoms and elevated markers should assist providers in diagnosing patients with CVID–IBD.